Michael Jenkins Joins Leerink Swann

Michael Jenkins has joined healthcare I-bank Leerink Swann as a senior managing director and head of Leerink Swann Strategic Advisors. He previously was a partner with Trinsum.

 

PRESS RELEASE

 

Healthcare investment bank Leerink Swann announced that Michael Jenkins has joined the firm as Senior Managing Director and Head of Leerink Swann Strategic Advisors.

 

Prior to joining Leerink, Mr. Jenkins was a Partner with Trinsum, formerly Marakon Associates, where he served clients in healthcare and financial services for more than 15 years, and most recently led the firm’s private equity practice. He brings deep experience and expertise in strategy development, strategy execution and performance delivery, acquisition evaluation and integration, and the design and delivery of initiatives to improve organizational effectiveness.

 

“Leerink Swann has built a knowledge platform and advisory capabilities that deliver unequalled value to healthcare companies and investors,” said Michael Jenkins. “The firm is well-positioned for growth and I’m excited to further capitalize on the vast number of opportunities available and help expand our role as trusted advisors to our clients.”

 

Mr. Jenkins holds a MBA in Management from The Wharton School at the University of Pennsylvania and a BBA in Finance from the University of Texas, Austin.

 

“I’m delighted to welcome Michael to the Firm. His experience ideally suits him for both building our Strategic Advisory practice and enhancing our ability to provide an integrated suite of services to our clients,” said Jeffrey A. Leerink, Chairman and CEO of Leerink Swann. “Michael’s understanding of the intersection between healthcare and financial services will be an important asset for our clients who require both banking and strategic advisory services.”

 

About Leerink Swann

 

Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory, and asset management services for institutional, life sciences, and high-net-worth clients. Every year since 2001, Institutional Investor has named Leerink Swann “Best of the Boutiques” in several healthcare categories. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member of FINRA/SIPC. For more information, visit www.leerink.com.